Endometrin Insert
NDC Package 55566-6500-3
Package Information
Endometrin (progesterone) inserts is this medication contains a female hormone called progesterone. This formulation utilizes a insert delivery system. Marketed by Ferring Pharmaceuticals Inc., this product is identified by NDC 55566-6500 and is authorized under FDA application NDA022057.
Identification & Billing
- RxCUI: 725094 - progesterone 100 MG Vaginal Tablet
- RxCUI: 725094 - progesterone 100 MG Vaginal Insert
- RxCUI: 725098 - Endometrin 100 MG Vaginal Insert
- RxCUI: 725098 - progesterone 100 MG Vaginal Insert [Endometrin]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 55566 - Ferring Pharmaceuticals Inc.
- 55566-6500 - Endometrin
- 55566-6500-3 - 1 CARTON in 1 CARTON / 21 BLISTER PACK in 1 CARTON (55566-6500-2) / 1 INSERT in 1 BLISTER PACK (55566-6500-1)
- 55566-6500 - Endometrin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (55566-6500). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55566-6500-3 identifies a specific commercial package of 1 carton in 1 carton / 21 blister pack in 1 carton (55566-6500-2) / 1 insert in 1 blister pack (55566-6500-1) of Endometrin, a human prescription drug labeled by Ferring Pharmaceuticals Inc.. This insert is formulated for vaginal use and contains progesterone as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ferring Pharmaceuticals Inc. on June 21, 2007. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication contains a female hormone called progesterone. Progesterone is needed to prepare the lining of the uterus so it can receive a fertilized egg. Progesterone and other hormones help you become and stay pregnant. This medication is used to increase the level of progesterone in women taking fertility treatments because these treatments tend to decrease progesterone levels.
How is this Ferring Pharmaceuticals Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55566650003. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.